Laboratory Corporation of America Holdings (LH) 101.31 $LH
ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation
Business Wire - Thu Apr 17, 7:30AM CDT
--Atrial Fibrillation Estimated Global Prevalence of 33.5 Million Patients in 2010
Laboratory Corp of America Holdings Rises 1.31% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 14, 4:51PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.19 to a high of $101.05. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $101.00 on volume of 878,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend Watching for Potential Pullback in Shares of Laboratory Corp of America Holdings After 1.31% Gain
Comtex SmarTrend(R) - Mon Apr 14, 4:49PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.19 to a high of $101.05. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $101.00 on volume of 878,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Laboratory Service Providers Should Profit From This New Revenue Source
Bob Chandler, The Motley Fool - Motley Fool - Mon Apr 14, 1:30PM CDT
Medical testing leaders such as Laboratory Corporation of America and Quest Diagnostics have disappointed investors with little to no sales and profit growth over the past couple years. Sluggish demand and collapsing prices have smothered...
Notes Conversion Offers, Stock Price Updates, Awards and Recognitions, and Tie-Ups - Analyst Notes on LabCorp, Endo Pharmaceuticals, Cognizant, YY, and Yandex
PR Newswire - Wed Apr 09, 8:21AM CDT
Today, Analysts Review released its analysts' notes regarding Laboratory Corp. of America Holdings (NYSE: LH), Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), Cognizant Technology Solutions Corporation (NASDAQ: CTSH), YY Inc. (NASDAQ: YY), and Yandex N.V. (NASDAQ: YNDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Healthcare Companies Report Recognitions, Schedules, and Stock Movements - Analyst Notes on WellPoint, Quest Diagnostics, LabCorp, Covance, and Masimo
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding WellPoint Inc. (NYSE: WLP), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Covance Inc. (NYSE: CVD), and Masimo Corporation (NASDAQ: MASI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Better Buy: Laboratory Corp Vs. Quest Diagnostics
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 9:58PM CDT
Lab services may not be the first investment idea you consider when thinking about warm weather plays, but maybe it should be. Major lab services plays Laboratory Corp and Quest Diagnostics both remind investors in their annual reports that...
When Harsh Medicare Cuts Are Cause for Celebration
David Williamson, The Motley Fool - Motley Fool - Wed Apr 02, 6:53PM CDT
Another of today's winners in the health-care space is Myriad Genetics , up 11% today after Medicare reimbursement cuts were announced. Though the cuts were harsh, they were lower than the market had been fearing, and Myriad came out on top as a...
Laboratory Corp of America Holdings Rises 4.13% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 01, 5:40PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.74 to a high of $102.65. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $99.15 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
After Yesterday's Rally of 4.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 01, 5:40PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.74 to a high of $102.65. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $99.15 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Will This Upgrade Help Laboratory Corp. of America (LH) Today?
at The Street - Tue Apr 01, 8:23AM CDT
UBS upgrades Laboratory Corp. of America (LH) to 'buy' from 'hold,' raising its price target to $112 from $93, citing the the lab industry's successful efforts to push off Medicare CLFS changes until 2017.
Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
Business Wire - Tue Apr 01, 7:30AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.
Upgrade Alert for Laboratory Corp of America Holdings (LH)
Comtex SmarTrend(R) - Tue Apr 01, 7:07AM CDT
Laboratory Corp of America Holdings (NYSE:LH) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $98.21 on volume of 654,000 shares, below average daily volume of 1.1 million. Based on a current price of $98.21, Laboratory Corp of America Holdings is currently 0.4% above its average consensus analyst price target of $97.85. Laboratory Corp of America Holdings shares have support at the 200-day moving average (MA) of $96.94 and additional support at the 50-day MA of $93.16.
LabCorp Announces Changes to Board of Directors
Business Wire - Mon Mar 31, 7:30AM CDT
--Board of Directors at the End of Their Current Terms;
Health Care Equities Technical Momentum -- Research on Laboratory Corp. of America, Omnicare, DaVita HealthCare Partners, and MEDNAX
PR Newswire - Fri Mar 28, 9:17AM CDT
On Wednesday, March 26, 2014, the NASDAQ Composite finished at 4,173.58, down 1.43%, the Dow Jones Industrial Average fell by 0.60% to close the session at 16,268.99, and the S&P 500 ended the day at 1,852.56, down 0.70%. The losses were broad based with nine out of ten sectors ending the session in negative. The S&P 500 Health Care Sector Index finished the day at 672.05, up 0.05%, and the same has gained 4.63% in the last three months. Investor-Edge has initiated coverage on the following equities: Laboratory Corp. of America Holdings (NYSE: LH), Omnicare Inc. (NYSE: OCR), DaVita HealthCare Partners Inc. (NYSE: DVA), and MEDNAX Inc. (NYSE: MD). Free technical research on LH, OCR, DVA, and MD can be downloaded upon signing up at:
Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Thu Mar 27, 4:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4qf5z/prenatal_and) has announced the addition of the "Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. This report studies the global prenatal and newborn genetic testing market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by technology has been segmented as diagnostic technique and screening methods. Diagnostic technique is further classified as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as non-invasive prenatal tests and maternal serum screening. Key Topics Covered: Introduction Executive Summary Prenatal and Newborn Genetic Testing Market Overview Prenatal and Newborn Genetic Testing Market, by Technology Prenatal and Newborn Genetic Testing Market, by Geography Competitive Landscape Recommendations Company Profiles List of Figures List of Tables Companies Mentioned - Agilent Technologies, Inc. - Ariosa Diagnostics, Inc. - Bio-Rad Laboratories, Inc. - Illumina, Inc. - Laboratory Corporation of America Holdings (LabCorp) - Natera, Inc. - PerkinElmer, Inc. - Sequenom, Inc. For more information visit http://www.researchandmarkets.com/research/r4...enatal_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Watch for Laboratory Corp of America Holdings to Potentially Pullback After Gaining 4.15% Yesterday
Comtex SmarTrend(R) - Wed Mar 26, 3:56PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $97.50 to a high of $102.00. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $97.84 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend Watching for Potential Pullback in Shares of Laboratory Corp of America Holdings After 4.15% Gain
Comtex SmarTrend(R) - Wed Mar 26, 3:55PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $97.50 to a high of $102.00. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $97.84 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NYSE stocks posting largest percentage increases
AP - Wed Mar 26, 12:16PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
Trade-Ideas: Laboratory Corporation Of America Holdings (LH) Is Today's "Barbarian At The Gate" Stock
at The Street - Wed Mar 26, 8:48AM CDT
Trade-Ideas LLC identified Laboratory Corporation of America Holdings (LH) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation
Business Wire - Thu Apr 17, 7:30AM CDT
--Atrial Fibrillation Estimated Global Prevalence of 33.5 Million Patients in 2010
Laboratory Corp of America Holdings Rises 1.31% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Apr 14, 4:51PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.19 to a high of $101.05. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $101.00 on volume of 878,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend Watching for Potential Pullback in Shares of Laboratory Corp of America Holdings After 1.31% Gain
Comtex SmarTrend(R) - Mon Apr 14, 4:49PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.19 to a high of $101.05. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $101.00 on volume of 878,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Laboratory Service Providers Should Profit From This New Revenue Source
Bob Chandler, The Motley Fool - Motley Fool - Mon Apr 14, 1:30PM CDT
Medical testing leaders such as Laboratory Corporation of America and Quest Diagnostics have disappointed investors with little to no sales and profit growth over the past couple years. Sluggish demand and collapsing prices have smothered...
Notes Conversion Offers, Stock Price Updates, Awards and Recognitions, and Tie-Ups - Analyst Notes on LabCorp, Endo Pharmaceuticals, Cognizant, YY, and Yandex
PR Newswire - Wed Apr 09, 8:21AM CDT
Today, Analysts Review released its analysts' notes regarding Laboratory Corp. of America Holdings (NYSE: LH), Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP), Cognizant Technology Solutions Corporation (NASDAQ: CTSH), YY Inc. (NASDAQ: YY), and Yandex N.V. (NASDAQ: YNDX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Healthcare Companies Report Recognitions, Schedules, and Stock Movements - Analyst Notes on WellPoint, Quest Diagnostics, LabCorp, Covance, and Masimo
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding WellPoint Inc. (NYSE: WLP), Quest Diagnostics Inc. (NYSE: DGX), Laboratory Corp. of America Holdings (NYSE: LH), Covance Inc. (NYSE: CVD), and Masimo Corporation (NASDAQ: MASI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Better Buy: Laboratory Corp Vs. Quest Diagnostics
Todd Campbell, The Motley Fool - Motley Fool - Thu Apr 03, 9:58PM CDT
Lab services may not be the first investment idea you consider when thinking about warm weather plays, but maybe it should be. Major lab services plays Laboratory Corp and Quest Diagnostics both remind investors in their annual reports that...
When Harsh Medicare Cuts Are Cause for Celebration
David Williamson, The Motley Fool - Motley Fool - Wed Apr 02, 6:53PM CDT
Another of today's winners in the health-care space is Myriad Genetics , up 11% today after Medicare reimbursement cuts were announced. Though the cuts were harsh, they were lower than the market had been fearing, and Myriad came out on top as a...
Laboratory Corp of America Holdings Rises 4.13% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Apr 01, 5:40PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.74 to a high of $102.65. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $99.15 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
After Yesterday's Rally of 4.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Apr 01, 5:40PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $99.74 to a high of $102.65. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $99.15 on volume of 2.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Will This Upgrade Help Laboratory Corp. of America (LH) Today?
at The Street - Tue Apr 01, 8:23AM CDT
UBS upgrades Laboratory Corp. of America (LH) to 'buy' from 'hold,' raising its price target to $112 from $93, citing the the lab industry's successful efforts to push off Medicare CLFS changes until 2017.
Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
Business Wire - Tue Apr 01, 7:30AM CDT
Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below.
Upgrade Alert for Laboratory Corp of America Holdings (LH)
Comtex SmarTrend(R) - Tue Apr 01, 7:07AM CDT
Laboratory Corp of America Holdings (NYSE:LH) was upgraded from Neutral to Buy at UBS today. The stock closed yesterday at $98.21 on volume of 654,000 shares, below average daily volume of 1.1 million. Based on a current price of $98.21, Laboratory Corp of America Holdings is currently 0.4% above its average consensus analyst price target of $97.85. Laboratory Corp of America Holdings shares have support at the 200-day moving average (MA) of $96.94 and additional support at the 50-day MA of $93.16.
LabCorp Announces Changes to Board of Directors
Business Wire - Mon Mar 31, 7:30AM CDT
--Board of Directors at the End of Their Current Terms;
Health Care Equities Technical Momentum -- Research on Laboratory Corp. of America, Omnicare, DaVita HealthCare Partners, and MEDNAX
PR Newswire - Fri Mar 28, 9:17AM CDT
On Wednesday, March 26, 2014, the NASDAQ Composite finished at 4,173.58, down 1.43%, the Dow Jones Industrial Average fell by 0.60% to close the session at 16,268.99, and the S&P 500 ended the day at 1,852.56, down 0.70%. The losses were broad based with nine out of ten sectors ending the session in negative. The S&P 500 Health Care Sector Index finished the day at 672.05, up 0.05%, and the same has gained 4.63% in the last three months. Investor-Edge has initiated coverage on the following equities: Laboratory Corp. of America Holdings (NYSE: LH), Omnicare Inc. (NYSE: OCR), DaVita HealthCare Partners Inc. (NYSE: DVA), and MEDNAX Inc. (NYSE: MD). Free technical research on LH, OCR, DVA, and MD can be downloaded upon signing up at:
Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Thu Mar 27, 4:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4qf5z/prenatal_and) has announced the addition of the "Prenatal and New-born Genetic Testing Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. Prenatal testing and diagnosis have enabled the detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also helps to determine the sex of the fetus. Prenatal and newborn genetic testing is referred to as the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome. This report studies the global prenatal and newborn genetic testing market from two perspectives namely, types of technologies and the major geographic markets. The global prenatal and newborn genetic testing market by technology has been segmented as diagnostic technique and screening methods. Diagnostic technique is further classified as polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH) and array-comparative genomic hybridization (aCGH). Similarly, screening methods are further categorized as non-invasive prenatal tests and maternal serum screening. Key Topics Covered: Introduction Executive Summary Prenatal and Newborn Genetic Testing Market Overview Prenatal and Newborn Genetic Testing Market, by Technology Prenatal and Newborn Genetic Testing Market, by Geography Competitive Landscape Recommendations Company Profiles List of Figures List of Tables Companies Mentioned - Agilent Technologies, Inc. - Ariosa Diagnostics, Inc. - Bio-Rad Laboratories, Inc. - Illumina, Inc. - Laboratory Corporation of America Holdings (LabCorp) - Natera, Inc. - PerkinElmer, Inc. - Sequenom, Inc. For more information visit http://www.researchandmarkets.com/research/r4...enatal_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Watch for Laboratory Corp of America Holdings to Potentially Pullback After Gaining 4.15% Yesterday
Comtex SmarTrend(R) - Wed Mar 26, 3:56PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $97.50 to a high of $102.00. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $97.84 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SmarTrend Watching for Potential Pullback in Shares of Laboratory Corp of America Holdings After 4.15% Gain
Comtex SmarTrend(R) - Wed Mar 26, 3:55PM CDT
Laboratory Corp of America Holdings (NYSE:LH) traded in a range yesterday that spanned from a low of $97.50 to a high of $102.00. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $97.84 on volume of 4.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
NYSE stocks posting largest percentage increases
AP - Wed Mar 26, 12:16PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:
Trade-Ideas: Laboratory Corporation Of America Holdings (LH) Is Today's "Barbarian At The Gate" Stock
at The Street - Wed Mar 26, 8:48AM CDT
Trade-Ideas LLC identified Laboratory Corporation of America Holdings (LH) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
